OCT Angiography: Vascular Imaging Without a Dye

For sixty years, seeing the retinal blood vessels in detail meant injecting a dye into a patient’s arm and photographing it as it passed through the eye.

Fluorescein angiography is invasive, time-consuming, and carries a small but real risk of allergic reaction.

OCT angiography (OCTA) produces comparable, often more detailed, vascular images from a scan lasting a few seconds – with no dye, no injection, and no risk.

It does this by detecting movement rather than light absorption, which is a genuinely different way of imaging blood flow.

That difference in physics is also exactly why OCTA cannot fully replace dye angiography – each technique reveals something the other cannot.

What Is OCT Angiography?

OCT angiography is a non-invasive imaging technique that visualises retinal and choroidal blood flow by detecting motion contrast between repeated OCT scans of the same retinal location.

Understanding what it visualises requires knowing the four capillary layers it can independently image:

The superficial capillary plexus, in the nerve fibre and ganglion cell layers
The deep capillary plexus, at the inner nuclear layer
The choriocapillaris, immediately beneath Bruch membrane
In disease, an additional pathological layer such as a choroidal neovascular membrane can be segmented and visualised in isolation

This depth-resolved capability is OCTA’s defining advantage – dye angiography compresses all of these layers into a single flattened image, while OCTA can separate them.

How OCT Angiography Works

Repeated OCT B-scans are acquired at the same retinal location in rapid succession
Static tissue produces an identical signal on each repeated scan; moving erythrocytes within blood vessels produce a decorrelation signal between scans
Software algorithms extract this motion contrast and generate a map of perfused vasculature, with no dye required
Automated or manual segmentation assigns the flow signal to specific anatomical layers, producing separate en-face angiograms for each plexus

Because the whole process relies purely on detecting motion, it can be repeated as often as needed without any cumulative patient risk – a genuinely different economics of imaging compared with dye-based studies.

Clinical Applications

Neovascular Age-Related Macular Degeneration

Direct visualisation of choroidal neovascular membranes without waiting for dye leakage to develop, allowing faster diagnosis
Detection of subclinical or non-exudative neovascularisation before it becomes clinically active, relevant to monitoring eyes at risk of conversion

Diabetic Retinopathy

Visualisation of capillary non-perfusion and enlargement of the foveal avascular zone, both markers of ischaemic severity
Detection of early microvascular changes that may precede clinically visible retinopathy on fundus examination

Vascular Occlusive Disease

Mapping the extent of capillary non-perfusion in retinal vein and artery occlusion, informing prognosis and the risk of neovascular complications

Glaucoma

Quantification of peripapillary and macular capillary density, an area of active research as a potential structural biomarker alongside optic nerve head OCT

The diabetic and occlusive disease applications are where OCTA has moved furthest from being a novelty toward genuine day-to-day clinical utility, because non-perfusion maps directly inform management decisions.

OCTA Versus Fluorescein Angiography

Advantages of OCTA

Non-invasive, with no injection, no allergic reaction risk and no contraindication in renal impairment or pregnancy
Rapid acquisition, typically a few seconds per scan, compared with several minutes for a full dye angiogram sequence
Depth-resolved imaging of individual capillary plexuses, which dye angiography cannot separate
Can be repeated freely for serial monitoring without cumulative risk

Limitations Compared With Dye Angiography

Cannot show dynamic leakage, which remains the defining feature of active exudation on fluorescein angiography
Smaller field of view in most standard acquisitions, though widefield OCTA systems are narrowing this gap
Prone to motion, blink and segmentation artefacts that can mimic or obscure true pathology
Cannot detect leakage from the retinal pigment epithelium or systemic sources of dye pooling in the way indocyanine green angiography can

The two techniques answer different questions – OCTA shows where vessels are and are not, while dye angiography shows where they are actively leaking – which is why most retina services use them as complementary tools rather than choosing one over the other.

Interpretation Pitfalls

Segmentation errors, where the software misassigns flow signal to the wrong layer, are common in eyes with significant retinal structural distortion
Projection artefact, where superficial vessel shadows appear falsely in deeper segmented layers, can mimic pathological neovascularisation
Poor fixation, media opacity and blink artefacts degrade image quality and can produce false areas of apparent non-perfusion
Correlating OCTA findings with the structural OCT B-scan and, where needed, with clinical examination remains essential rather than optional

Projection artefact is probably the single most common source of a false-positive neovascular membrane read on OCTA, and recognising it is a core skill for anyone interpreting these scans.

Prognosis for the Technology

OCT angiography has moved from a research tool to routine clinical equipment in a little over a decade.

Widefield OCTA systems are progressively closing the field-of-view gap with dye angiography
Quantitative metrics – vessel density, non-perfusion area, foveal avascular zone size – are increasingly used as trial endpoints and are being explored as early biomarkers across diabetic, occlusive and neurodegenerative disease
Artificial intelligence-assisted artefact detection and automated quantification are active areas of development, aiming to reduce the interpretation pitfalls above
OCTA has not eliminated the need for dye angiography, and is unlikely to for as long as dynamic leakage remains clinically important information

The realistic trajectory is complementary coexistence rather than replacement – OCTA has taken over the questions it answers better, and dye angiography has kept the ones it still answers alone.

References

Spaide RF, Fujimoto JG, Waheed NK, et al. Optical coherence tomography angiography. Progress in Retinal and Eye Research. 2018.
Jia Y, Bailey ST, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2014.
de Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA). International Journal of Retina and Vitreous. 2015.
OCT Angiography. EyeWiki, American Academy of Ophthalmology.
Optical Coherence Tomography Angiography. StatPearls, NCBI Bookshelf.